跳至主要内容
临床试验/ISRCTN32335415
ISRCTN32335415进行中(未招募)未知

Investigation of novel plasma Human Papilloma Virus DNA assay for treatment response estimation in head and neck cancer

The Institute of Cancer Research, London0 个研究点目标入组 191 人开始时间: 2020年3月3日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
191

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged 18 years or above.
  • 2. Newly diagnosed patients with T1-T2/N1-3 or T3-T4/ N0-3 squamous cell carcinoma of the oropharynx
  • 3. Availability of tissue from one archival diagnostic tumour tissue block
  • 4. Confirmed HPV status (p16InK4A IHC/ISH)
  • 5. Patients must be candidates for and willing to undergo curative RT/CRT
  • 6. Written informed consent

排除标准

  • 1. Previous or concurrent illness or situation, which in the investigator’s opinion would interfere with collection of the complete sample collection
  • 2. Any invasive malignancy within previous 5 years (other than non melanomatous skin carcinoma or cervical carcinoma in situ
  • 3. Clinical evidence of metastatic disease

研究者

发起方
The Institute of Cancer Research, London

相似试验